Home Editorial 2: Editorial from the CEO
Article
Licensed
Unlicensed Requires Authentication

Editorial 2: Editorial from the CEO

  • Beat Löffler,
Published/Copyright: May 1, 2010
Become an author with De Gruyter Brill
Author Information
European Journal of Nanomedicine
From the journal European Journal of Nanomedicine Volume 3 Issue 1

Published Online: 2010-05
Published in Print: 2010-05

©2011 by Walter de Gruyter GmbH & Co.

Articles in the same Issue

  1. Editorial 1: Clinical Nanomedicine, a New Nano Domain
  2. Editorial 2: Editorial from the CEO
  3. Editorial 3: Nanomedicine – shaping the future of medicine in a context of academia, industry and politics
  4. Clinical Nanomedicine: Nanomedical approaches in Alzheimer’s disease
  5. Nanophysiology: The Janus Face of Immune Stimulation by Nanomedicines: Examples for the Good and the Bad
  6. Therapeutic Nanomedicine: Cross linked micelles with transiently linked drugs – a versatile drug delivery system
  7. Preventive Nanomedicine: Nanomedicine for dendritic cell-targeted immunotherapy
  8. Nanomethods: Scanning X-ray scattering: Evaluating the nanostructure of human tissues
  9. Nanopharmaceuticals: Nanopharmaceuticals
  10. The Landscape of Nanomedicine: Nanomedicine and Nanotoxicology at PHARMA–Copenhagen University
https://doi.org/10.1515/EJNM.2010.3.1.5

Articles in the same Issue

  1. Editorial 1: Clinical Nanomedicine, a New Nano Domain
  2. Editorial 2: Editorial from the CEO
  3. Editorial 3: Nanomedicine – shaping the future of medicine in a context of academia, industry and politics
  4. Clinical Nanomedicine: Nanomedical approaches in Alzheimer’s disease
  5. Nanophysiology: The Janus Face of Immune Stimulation by Nanomedicines: Examples for the Good and the Bad
  6. Therapeutic Nanomedicine: Cross linked micelles with transiently linked drugs – a versatile drug delivery system
  7. Preventive Nanomedicine: Nanomedicine for dendritic cell-targeted immunotherapy
  8. Nanomethods: Scanning X-ray scattering: Evaluating the nanostructure of human tissues
  9. Nanopharmaceuticals: Nanopharmaceuticals
  10. The Landscape of Nanomedicine: Nanomedicine and Nanotoxicology at PHARMA–Copenhagen University
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 29.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/EJNM.2010.3.1.5/html
Scroll to top button